JPRN-UMIN000003702已完成1 期
Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption - Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption
Takuo Ogihara0 个研究点目标入组 6 人开始时间: 2010年8月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- •the investigators must ensure that all subjects being considered to meet the following exclusion criteria or conditions: 1)history of allergy to Oseltamivir 2)difficult to take milk because of lactose intolerance etc. 3)disease thought to be decreased metabolic function of liver(acute hepatitis,chronic hepatitis,hepatic cirrhosis,liver carcinoma,jaundice) 4)decreased metabolic function of kidney 5)electrocardiogram (ECG) showing a QTc>460 msec 6)who take any drugs or supplement including St.John's wort within a week prior to test drug administration 7)fruit juice including grapefruit, orange or apple within 7 days prior to test drug administration 8)recent (past 3 months) participation in other clinical trial for investigational agent,the investigator determines this trial participation inadequate 9)donation of 400mL or more of blood within 3 months prior to participation, donation of 200mL or more of blood within 1 month prior to participation 10)any positive results of HBs-AG,HCV-AB,HIV AB,HIV AG,TPHA. 11)history of allergy to any medicines and foods 12)history of drug or alcohol abusement 13) the investigator determines inadequate
研究者
相似试验
已完成
1 期
Single Dose and Multiple Dose Safety, Tolerability, PK,and Food Effect Study,and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult SubjectsInfluenzaNCT04982913Sunshine Lake Pharma Co., Ltd.118
已完成
4 期
Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD)Critically Ill Renal Failure Requiring CVVHD and OseltamivirCritically Ill Requiring ECMO and OseltamivirNCT01048879University of Michigan15
已完成
4 期
Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.InfluenzaNCT00304434US Department of Veterans Affairs48
已完成
1 期
A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu InfectionInfluenzaNCT00988325Hoffmann-La Roche65
已完成
不适用
A Study of the Pharmacology of Tamiflu in PregnancyH1N1 Influenza Treatment During PregnancyNCT01203527Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)63
